137 related articles for article (PubMed ID: 17322546)
1. Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.
De Ruysscher D; Dehing C; Bremer RH; Bentzen SM; Koppe F; Pijls-Johannesma M; Harzée L; Minken A; Wanders R; Hochstenbag M; Dingemans AM; Boersma L; van Haren E; Geraedts W; Pitz C; Simons J; Wouters B; Rosier JF; Lambin P
Ann Oncol; 2007 May; 18(5):909-16. PubMed ID: 17322546
[TBL] [Abstract][Full Text] [Related]
2. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
Singh AK; Lockett MA; Bradley JD
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
[TBL] [Abstract][Full Text] [Related]
4. Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients.
Dehing-Oberije C; De Ruysscher D; Petit S; Van Meerbeeck J; Vandecasteele K; De Neve W; Dingemans AM; El Naqa I; Deasy J; Bradley J; Huang E; Lambin P
Radiother Oncol; 2010 Dec; 97(3):455-61. PubMed ID: 21084125
[TBL] [Abstract][Full Text] [Related]
5. Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
Maguire PD; Sibley GS; Zhou SM; Jamieson TA; Light KL; Antoine PA; Herndon JE; Anscher MS; Marks LB
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):97-103. PubMed ID: 10477012
[TBL] [Abstract][Full Text] [Related]
6. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.
Bradley J; Deasy JO; Bentzen S; El-Naqa I
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1106-13. PubMed ID: 15001251
[TBL] [Abstract][Full Text] [Related]
8. Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
Tang C; Lee MS; Gomez D; Levy LB; Zhuang Y; Lu C; Liao Z; Komaki R
Am J Clin Oncol; 2017 Dec; 40(6):625-630. PubMed ID: 26165417
[TBL] [Abstract][Full Text] [Related]
9. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.
Zhang ZC; Xu J; Li BS; Zhou T; Lu J; Wang ZT; Li HS; Sun HF; Zhu J; Yu JM
Am J Clin Oncol; 2010 Jun; 33(3):271-5. PubMed ID: 19823071
[TBL] [Abstract][Full Text] [Related]
10. Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer.
Everitt S; Duffy M; Bressel M; McInnes B; Russell C; Sevitt T; Ball D
Radiat Oncol; 2016 Feb; 11():20. PubMed ID: 26864559
[TBL] [Abstract][Full Text] [Related]
11. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.
Wijsman R; Dankers F; Troost EG; Hoffmann AL; van der Heijden EH; de Geus-Oei LF; Bussink J
Radiother Oncol; 2015 Oct; 117(1):49-54. PubMed ID: 26341608
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
Movsas B; Scott C; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Smith C; Axelrod R; Sarna L; Wasserman T; Byhardt R
J Clin Oncol; 2005 Apr; 23(10):2145-54. PubMed ID: 15800308
[TBL] [Abstract][Full Text] [Related]
13. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.
Werner-Wasik M; Pequignot E; Leeper D; Hauck W; Curran W
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):689-96. PubMed ID: 11020565
[TBL] [Abstract][Full Text] [Related]
14. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
[TBL] [Abstract][Full Text] [Related]
15. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.
Belderbos J; Heemsbergen W; Hoogeman M; Pengel K; Rossi M; Lebesque J
Radiother Oncol; 2005 May; 75(2):157-64. PubMed ID: 15890421
[TBL] [Abstract][Full Text] [Related]
16. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
Lebeau B; Urban T; Bréchot JM; Paillotin D; Vincent J; Leclerc P; Meekel P; L'Her P; Lebas FX; Chastang C
Cancer; 1999 Oct; 86(8):1480-7. PubMed ID: 10526276
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines.
Hügli A; Moro D; Mermillod B; Bolla M; Alberto P; Bonnefoi H; Miralbell R
J Clin Oncol; 2000 Apr; 18(8):1662-7. PubMed ID: 10764426
[TBL] [Abstract][Full Text] [Related]
19. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
[TBL] [Abstract][Full Text] [Related]
20. Radiographic changes following radiotherapy in the patients with lung cancer. Is the irradiated area of the mediastinum in the simulation film a significant factor?
Yamazaki H; Tang JT; Inoue T; Teshima T; Ohtani M; Ikeda H; Itou M; Takeuchi E; Inoue T
Strahlenther Onkol; 1995 May; 171(5):272-7. PubMed ID: 7770782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]